Board Change: Non-Executive Director Appointment
Sharmila Nebhrajani appointed Non-Executive Director, effective 1 January 2027.
Select text to share a quote on X · sign in to keep highlights & notes in your GNS notes
Genus (LSE: GNS), a leading global animal genetics company, is pleased to announce the appointment of Sharmila Nebhrajani to the Board as a Non-Executive Director, with effect from 1 January 2027.
Ms Nebhrajani is a Chartered Accountant with extensive experience in public sector, commercial, government and non-profit organisations across a wide range of sectors, having worked in senior roles in public health and medical research, working with government, medical charities and pharmaceutical industry partners, and latterly in government, convening international policy dialogue with governments, multi-lateral agencies, NGOs, senior policy makers and academics, on key global policy issues. Her appointment follows an extensive search process using an external search agency.
Ms Nebhrajani has a MA in Physiological Sciences from Oxford University and is currently a non-executive director and remuneration committee chair of Severn Trent plc[1], non-executive director and remuneration committee chair of ITV plc, senior independent director and audit committee chair of Halma plc, non-executive director of Essentra plc and Chair of the National Institute for Health and Care Excellence. She was previously a non-executive director of Coutts & Co.
Commenting on the appointment, Iain Ferguson, Chair of Genus, said:
“We are delighted to welcome Shar to the Board. Shar is a highly experienced non-executive director and audit committee chair, and brings a broad range of commercial, strategic and scientific experience and knowledge.”
Regulatory Notes
Details of any payments to be made to Sharmila Nebhrajani will be disclosed in full in the Company’s 2027 Directors’ Remuneration Report. Any such terms will be consistent with the Company's approved Directors’ Remuneration Policy.
This announcement is made in accordance with Listing Rule 6.4.6R. There are no matters to be disclosed in connection with Listing Rule 6.4.8R (2) – (6).
[1] Sharmila will step down from the Board of Severn Trent plc on 30 November 2026.
Cleaned text: letterheads, contacts and legal notices removed. Official copy: FCA National Storage Mechanism ↗ · Company filings. Not investment advice.